BHC (Bausch Health) Shiller PE Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BHC Bausch Health Companies Inc BHC
57 GF Score
Price $6.37
GF Value $7.44
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bausch Health Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health  (NYSE:BHC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bausch Health Shiller PE Ratio Related Terms


Bausch Health Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Bausch Health's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Shiller PE Ratio Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bausch Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BHC vs ZTS: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Shiller PE Ratio falls into.


BHC
57GF Score
Bausch Health Companies Inc BHC
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bausch Health's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Bausch Health's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.68/133.5265*133.5265
=0.680

Current CPI (Jun. 2026) = 133.5265.

Bausch Health Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -3.490 101.765 -4.579
201612 -1.470 101.449 -1.935
201703 1.790 102.634 2.329
201706 -0.110 103.029 -0.143
201709 3.690 103.345 4.768
201712 1.450 103.345 1.873
201803 -7.360 105.004 -9.359
201806 -2.490 105.557 -3.150
201809 -1.000 105.636 -1.264
201812 -0.983 105.399 -1.245
201903 -0.150 106.979 -0.187
201906 -0.490 107.690 -0.608
201909 -0.140 107.611 -0.174
201912 -4.299 107.769 -5.326
202003 -0.430 107.927 -0.532
202006 -0.920 108.401 -1.133
202009 0.200 108.164 0.247
202012 -0.430 108.559 -0.529
202103 -1.710 110.298 -2.070
202106 -1.660 111.720 -1.984
202109 0.520 112.905 0.615
202112 0.190 113.774 0.223
202203 -0.190 117.646 -0.216
202206 -0.400 120.806 -0.442
202209 1.100 120.648 1.217
202212 -1.130 120.964 -1.247
202303 -0.550 122.702 -0.599
202306 0.070 124.203 0.075
202309 -1.030 125.230 -1.098
202312 -0.110 125.072 -0.117
202403 -0.170 126.258 -0.180
202406 0.030 127.522 0.031
202409 -0.230 127.285 -0.241
202412 0.250 127.364 0.262
202503 -0.160 129.181 -0.165
202506 0.400 129.892 0.411
202509 0.480 130.287 0.492
202512 -0.300 130.366 -0.307
202603 -3.820 132.262 -3.857
202606 0.680 133.527 0.680

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $6.37 is trading 14.4% below its estimated GF Value™ of $7.44. GuruFocus considers Bausch Health to be Modestly Undervalued.

Key valuation signals for BHC:

  • Shiller PE Ratio:
  • GF Value™: $7.44 vs. price of $6.37 (14.4% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
57GF Score

Get the complete analysis for BHC

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$7.44
GF Value